The antioxidant system of very low birth weight infants is immature. This immaturity is implicated in the pathogenesis of diseases such as bronchopulmonary dysplasia or retinopathy. The main source of oxidant is oxygen, and parenteral nutrition is contaminated with oxidant. Photoprotection decreases the oxidant load infused with parenteral nutrition. In a preliminary study, photoprotection reduced the frequency of pulmonary bronchodysplasia, increased the quantity of enteral nutrition tolerated, and decreased the arterial blood pressure among very low birth weight infants. The aim of this study is to evaluate the impact of photoprotection on oxidant related diseases among very low birth weight infants. This study is a randomized multicenter trial. In the intervention group, photoprotection is applied until the infusion of parenteral nutrition with amber bags, tubing, and syringes. The quality of photoprotection is controlled by measuring malondialdehyde and cysteine after 24 hours of infusion. The control group will receive parenteral nutrition with transparent bags and tubing. The outcomes are evaluated at 36 weeks, and 680 infants will be enrolled, with stratification among centers and gestational age.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
591
use of photoprotected parenteral nutrition device
Use of standard (transparent) parenteral nutrition device
Angelique Denis
Lyon, France
Death or bronchopulmonary dysplasia at 28 days
Time frame: 28 days
Retinopathy of prematurity
Time frame: 36 weeks
sepsis
Time frame: 28 days and 36 weeks
intraventricular hemorrhage
Time frame: 7 days, 24days, 36 weeks
periventricular leucomalacia
Time frame: 36 weeks
tolerance of enteral nutrition
Time frame: during enteral nutrition
enterocolitis
Time frame: 36 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.